NCT07196449View on ClinicalTrials.gov

Drug-Drug Interaction of Rifampicin and Cyclosporine on Methotrexate Pharmacokinetics in Healthy Subjects

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 14, 2025

Primary Completion Date

June 9, 2025

Study Completion Date

April 14, 2026

Conditions

Drug Drug Interaction (DDI)

Interventions

DRUG

Methotrexate

Methotrexate Tab. 2.5 mg (Korea United Pharm)

DRUG

Rifampicin

Rifampin Cap. 150 mg (Yuhan Corporation)

DRUG

Cyclosporine

Cypol-N Cap. 100 mg (Chong Kun Dang)

Trial Locations (1)

13605

Seoul National University Bundang Hospital, Seongnam-si

All Listed Sponsors

lead

Seoul National University Bundang Hospital

OTHER

NCT07196449 - Drug-Drug Interaction of Rifampicin and Cyclosporine on Methotrexate Pharmacokinetics in Healthy Subjects | Biotech Hunter | Biotech Hunter